|
🐜
|
Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics.
11 auth.
R. García-Sanz,
A. Órfão,
Marcos González,
M. Tabernero,
J. Bladé,
M. Moro,
...
J. Fernández-Calvo,
M. Sanz,
J. Pérez-Simón,
A. Rasillo,
J. F. Miguel
|
8 |
1999 |
8
🐜
|
|
🐜
|
Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma.
15 auth.
Mauricio Ocqueteau,
A. Órfão,
J. Almeida,
Joan,
Blade,
Marcos González,
R. García-Sanz,
C. López-Berges,
M. Moro,
J. Hernández,
...
L. Escribano,
D. Caballero,
María,
Rozman,
J. Miguel
|
7 |
1998 |
7
🐜
|
|
🐜
|
Prognostic value of numerical chromosome aberrations in multiple myeloma: A FISH analysis of 15 different chromosomes.
10 auth.
J. Pérez-Simón,
R. García-Sanz,
M. Tabernero,
J. Almeida,
Marcos González,
J. Fernández-Calvo,
...
M. Moro,
J. Hernandez,
J. Miguel,
A. Órfão
|
7 |
1998 |
7
🐜
|
|
🐜
|
Immunophenotypic evaluation of the plasma cell compartment in multiple myeloma: a tool for comparing the efficacy of different treatment strategies and predicting outcome.
12 auth.
J. S. San Miguel,
J. Almeida,
G. Mateo,
J. Bladé,
C. López-Berges,
D. Caballero,
...
J. Hernández,
M. Moro,
J. Fernández-Calvo,
J. Díaz-Mediavilla,
L. Palomera,
A. Órfão
|
7 |
2002 |
7
🐜
|
|
🐜
|
Immunophenotypic analysis of Waldenstrom's macroglobulinemia.
16 auth.
J. F. Miguel,
M. Vidriales,
E. Ocio,
G. Mateo,
F. Sánchez-Guijo,
M. Sanchez,
L. Escribano,
A. Bárez,
M. Moro,
J. Hernández,
...
C. Aguilera,
R. Cuello,
J. García-Frade,
R. López,
J. Portero,
A. Órfão
|
7 |
2003 |
7
🐜
|
|
🐜
|
Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia.
12 auth.
J. Ciudad,
J. S. San Miguel,
M. López-Berges,
B. Vidriales,
B. Valverde,
M. Ocqueteau,
...
G. Mateos,
M. Caballero,
J. Hernández,
M. Moro,
M. Mateos,
A. Órfão
|
7 |
1998 |
7
🐜
|
|
🐜
|
High‐sensitive immunophenotyping and DNA ploidy studies for the investigation of minimal residual disease in multiple myeloma
10 auth.
Julia Almeida,
A. Órfão,
M. Ocqueteau,
G. Mateo,
M. Corral,
M. Caballero,
...
J. Bladé,
M. Moro,
J. Hernández,
J. S. San Miguel
|
7 |
1999 |
7
🐜
|
|
🐜
|
Leukemias with megakaryoblastic involvement: clinical, hematologic, and immunologic characteristics.
9 auth.
J. S. San Miguel,
M. González,
M. C. Cañizo,
E. Ojeda,
A. Órfão,
M. Caballero,
...
M. Moro,
P. Fisac,
A. López Borrasca
|
6 |
1988 |
6
🐜
|
|
🐜
|
Immunophenotypic heterogeneity of multiple myeloma: influence on the biology and clinical course of the disease
14 auth.
J. G. Miguel,
M. Gonzáalez,
A. Gascón,
M. Moro,
J. M. Hernáandez,
Francisco Ortega,
R. Jiménez,
L. Guerras,
M. Romero,
F. Casanova,
...
M. Sanz,
J. Sâanchez,
J. A. Portero,
A. Órfão
|
6 |
1991 |
6
🐜
|
|
🐜
|
6q deletion in Waldenström macroglobulinemia is associated with features of adverse prognosis
19 auth.
E. Ocio,
R. Schop,
B. González,
S. V. Wier,
J. Hernández-Rivas,
N. Gutiérrez,
R. García-Sanz,
M. Moro,
C. Aguilera,
J. Hernandez,
...
Ruifang Xu,
P. Greipp,
A. Dispenzieri,
S. Jalal,
M. Lacy,
Natalia C Gonzalez-Paz,
M. Gertz,
J. F. Miguel,
R. Fonseca
|
6 |
2007 |
6
🐜
|
